ES2122387T3 - Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina. - Google Patents

Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.

Info

Publication number
ES2122387T3
ES2122387T3 ES95107128T ES95107128T ES2122387T3 ES 2122387 T3 ES2122387 T3 ES 2122387T3 ES 95107128 T ES95107128 T ES 95107128T ES 95107128 T ES95107128 T ES 95107128T ES 2122387 T3 ES2122387 T3 ES 2122387T3
Authority
ES
Spain
Prior art keywords
ranitidine
chlorhydrate
procedure
preparation
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95107128T
Other languages
English (en)
Inventor
Jag Mohan Khanna
Naresh Kumar
Brij Khera
Mahavir Singh Khanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23009921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2122387(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/265,307 external-priority patent/US5621120A/en
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Application granted granted Critical
Publication of ES2122387T3 publication Critical patent/ES2122387T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Abstract

SE PRESENTA UN PROCESO PARA LA MANUFACTURA DE HIDROCLORURO DE RANITIDINA DE FORMA 1 (HIDROCLORURO DE N-[2-[[[5(DIMETILAMINO)METIL]-2-FURANIL]METIL]TIO]ETIL-N''-METIL-2-NITRO1,1-ETENODIAMINO). TAMBIEN SE PRESENTA UN PROCESO PARA CONVERTIR EL HIDROCLORURO DE RANITIDINA DE LA FORMA 2 EN LA FORMA 1.
ES95107128T 1994-06-24 1995-05-11 Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina. Expired - Lifetime ES2122387T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/265,307 US5621120A (en) 1994-05-13 1994-06-24 Process for the manufacture of form 1 ranitidine hydrochloride

Publications (1)

Publication Number Publication Date
ES2122387T3 true ES2122387T3 (es) 1998-12-16

Family

ID=23009921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95107128T Expired - Lifetime ES2122387T3 (es) 1994-06-24 1995-05-11 Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.

Country Status (4)

Country Link
EP (1) EP0694540B1 (es)
DE (1) DE69504156T2 (es)
ES (1) ES2122387T3 (es)
PH (1) PH31401A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1972097A (en) * 1996-03-25 1997-10-17 Hoechst Marion Roussel, Inc. Process for the preparation of form 1 ranitidine hydrochloride
IT1311915B1 (it) * 1999-04-12 2002-03-20 Pharmexcel S R L Compressa anidra di cloridrato di ranitidina con rivestimento a doppiostrato e sua composizione.
CN104906069A (zh) * 2015-05-26 2015-09-16 苗怡文 一种治疗胃溃疡的药物盐酸雷尼替丁组合物胶囊
CN104971053A (zh) * 2015-08-05 2015-10-14 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化系统疾病的药物盐酸雷尼替丁组合物片剂
CN105055331A (zh) * 2015-08-31 2015-11-18 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化性溃疡的药物盐酸雷尼替丁组合物颗粒剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GR852557B (es) * 1985-10-23 1985-11-27 Chemica Farmakeutiki Viomihani
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
DE69504156T2 (de) 1998-12-24
EP0694540A1 (en) 1996-01-31
EP0694540B1 (en) 1998-08-19
PH31401A (en) 1998-10-29
DE69504156D1 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
BR9809112A (pt) Novo processo para preparação de uma substância farmacologicamente ativa
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
EA200200873A1 (ru) Новые пиперазиновые производные
ES2160534B1 (es) Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
TW200716520A (en) 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
EA199700124A1 (ru) Производные гуанина
AR051778A2 (es) Derivados del acido dimetilaminocrotonico y procesos para supreparacion
ATE306261T1 (de) Antithrombosemittel
FR2627696B1 (fr) Nouvelle forme galenique du fenofibrate
EA200200571A1 (ru) Новая композиция и ее применение
ES2133769T3 (es) Procedimiento para la sintesis diastereoselectiva de analogos de nucleosidos.
EP1797875A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
BR9809111A (pt) Novos intermediários e processo para sua preparação
SE9903291D0 (sv) New process
ES2091324T3 (es) Proceso para la preparacion de aspartama a partir de una dicetopiperazina y nuevos compuestos intermedios y derivados para dicho proceso.
HUP9700886A2 (hu) Új tienil-etilamino-halogénfenil-acetonitril intermedierek és eljárás előállításukra
EA200100301A3 (ru) НОВЫЙ СПОСОБ ПОЛУЧЕНИЯ 11-АМИНО-3-ХЛОР-6,11-ДИГИДРО-5,5-ДИОКСО-6-МЕТИЛДИБЕНЗО[c,f][1,2]ТИАЗЕПИНА И ЕГО ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ТИАНЕПТИНА
ES2122387T3 (es) Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
NO174198C (no) Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav
ES2188909T3 (es) Nuevos derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes o enfermedades relacionados con el estrogeno. os

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 694540

Country of ref document: ES